Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis

被引:39
|
作者
Lam, Andrew C. L. [1 ,2 ]
Aggarwal, Reenika [1 ,3 ]
Cheung, Serina [4 ]
Stewart, Erin L. [1 ]
Darling, Gail [5 ]
Lam, Stephen [6 ]
Xu, Wei [3 ,7 ]
Liu, Geoffrey [1 ,2 ,3 ,8 ]
Kavanagh, John [9 ]
机构
[1] Princess Margaret Canc Ctr, Div Med Oncol, 610 Univ Ave, University, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 1P8, Canada
[4] Univ Toronto, Inst Med Sci, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[5] Univ Hlth Network, Div Thorac Surg, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada
[6] British Columbia Canc Agcy, 675 West 10th Ave, Vancouver, BC V5Z 1G1, Canada
[7] Princess Margaret Canc Ctr, Dept Biostat, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
[8] Univ Toronto, Dept Med Biophys, 101 Coll St, Toronto, ON M5G 1L7, Canada
[9] Univ Hlth Network, Joint Dept Med Imaging, 263 McCaul St, Toronto, ON M5T 1W5, Canada
关键词
Lung cancer; Lung neoplasms; Cancer screening; Mass screening; Early detection of cancer; Computed tomography; Patient adherence; Patient compliance; Guideline adherence; Patient satisfaction; DOSE COMPUTED-TOMOGRAPHY; ANNUAL FOLLOW-UP; ADHERENCE; RISK; RECOMMENDATIONS; INTERVENTIONS; GUIDELINES; MORTALITY; STATEMENT; PROSTATE;
D O I
10.1016/j.lungcan.2020.05.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The low nonadherence rates reported by large low-dose computed tomography (LDCT) lung cancer screening trials were not necessarily replicated outside of trial conditions. This systematic review and meta-analysis identified predictors of participant nonadherence to returning for annual LDCT screening. The systematic review protocol was registered at PROSPERO (CRD42019118347). MEDLINE, EMBASE, CINAHL, AgeLine, grey literature sources, and reference lists of included studies were searched until March 1st, 2020. Primary research articles were eligible for inclusion if they screened current or former smokers using LDCT as their primary screening modality and reported on participant demographics or programmatic interventions that predicted nonadherence. Risk of bias assessment was performed at both study and outcome levels. The primary outcome was predictors of nonadherence. The secondary outcomes were relative risks (RR) of second round non-adherence based on identified predictors, which were calculated using random-effects meta-analyses. Across 13 included studies (total n = 15,790; range: 157-3642), the overall rate of nonadherence was 28% (95% CI: 20-37%). Studies identified greater nonadherence in participants younger than 60 or older than 74, with longer travel distances to screening centers, and having a low risk perception of lung cancer. Meta-analyses identified higher nonadherence in community-based compared to academic-based programs, but this did not reach significance (32% versus 27%; p = 0.32). Current smokers were more likely to be nonadherent compared to former smokers (RR 1.23, 95% CI: 1.09-1.40; p < 0.01) while white participants were less likely nonadherent compared to non-white participants (RR 0.69, 95% CI: 0.60-0.81; p < 0.0001). No differences existed between male and female participants (RR 0.99, 95% CI: 0.85-1.15; p = 0.85). Programmatic interventions, including dedicated program coordinators, reminder calls/letters, and mobile LDCT scanners reduced nonadherence in lung cancer screening programs. These interventions should be targeted/tailored toward the subpopulations with the highest nonadherence rates.
引用
收藏
页码:134 / 144
页数:11
相关论文
共 50 条
  • [31] Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials
    Li, Shuangjiang
    Zhou, Kun
    Che, Guowei
    Yang, Mei
    Su, Jianhua
    Shen, Cheng
    Yu, Pengming
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 657 - 670
  • [32] Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screening
    Alexandris, Panos
    Quaife, Samantha
    Berg, Christine D.
    Callister, Matthew
    Crosbie, Philip A. J.
    Davies, Michael P. A.
    de Koning, Harry J.
    Field, John K.
    Hammer, Mark M.
    Horst, Carolyn
    Janes, Sam
    Nair, Arjun
    Rintoul, Robert C.
    Gabe, Rhian
    Duffy, Stephen
    BMJ OPEN, 2025, 15 (01):
  • [33] Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysis
    Zair, Zoulikha M.
    Singer, Donald R. J.
    PHARMACOGENOMICS, 2016, 17 (09) : 1089 - 1115
  • [34] Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis
    Alsabbagh, M. H. D. Wasem
    Lemstra, Mark
    Eurich, Dean
    Lix, Lisa M.
    Wilson, Thomas W.
    Watson, Erin
    Blackburn, David F.
    VALUE IN HEALTH, 2014, 17 (02) : 288 - 296
  • [35] Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
    Burdett, Sarah
    Rydzewska, Larysa H. M.
    Tierney, Jayne F.
    Auperin, Anne
    Le Pechoux, Cecile
    Le Chevalier, Thierry
    Pignon, Jean-Pierre
    LANCET, 2014, 383 (9928): : 1561 - 1571
  • [36] Predictors of Poststroke Aphasia Recovery A Systematic Review-Informed Individual Participant Data Meta-Analysis
    Ali, Myzoon
    VandenBerg, Kathryn
    Williams, Linda J.
    Williams, Louise R.
    Abo, Masahiro
    Becker, Frank
    Bowen, Audrey
    Brandenburg, Caitlin
    Breitenstein, Caterina
    Bruehl, Stefanie
    Copland, David A.
    Cranfill, Tamara B.
    Di Pietro-Bachmann, Marie
    Enderby, Pamela
    Fillingham, Joanne
    Galli, Federica Lucia
    Gandolfi, Marialuisa
    Glize, Bertrand
    Godecke, Erin
    Hawkins, Neil
    Hilari, Katerina
    Hinckley, Jacqueline
    Horton, Simon
    Howard, David
    Jaecks, Petra
    Jefferies, Elizabeth
    Jesus, Luis M. T.
    Kambanaros, Maria
    Kang, Eun Kyoung
    Khedr, Eman M.
    Kong, Anthony Pak-Hin
    Kukkonen, Tarja
    Laganaro, Marina
    Ralph, Matthew A. Lambon
    Laska, Ann Charlotte
    Leemann, Beatrice
    Leff, Alexander P.
    Lima, Roxele R.
    Lorenz, Antje
    Mac Whinney, Brian
    Marshall, Rebecca Shisler
    Meinzer, Marcus
    Nilipour, Reza
    Noe, Enrique
    Paik, Nam-Jong
    Palmer, Rebecca
    Papathanasiou, Ilias
    Patricio, Brigida F.
    Martins, Isabel Pavao
    Price, Cathy
    STROKE, 2021, 52 (05) : 1778 - 1787
  • [37] Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis
    Brenner, Darren R.
    McLaughlin, John R.
    Hung, Rayjean J.
    PLOS ONE, 2011, 6 (03):
  • [38] Functional Lung Imaging in Radiotherapy for Lung Cancer: A Systematic Review and Meta-Analysis
    Bucknell, N.
    Hardcastle, N.
    Bressel, M.
    Hofman, M.
    Kron, T.
    Siva, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S853 - S854
  • [39] Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis
    Yang, Lei
    Wang, Shengfeng
    Zhang, Liwen
    Sheng, Chao
    Song, Fengju
    Wang, Ping
    Huang, Yubei
    BMC CANCER, 2020, 20 (01)
  • [40] Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis
    Lei Yang
    Shengfeng Wang
    Liwen Zhang
    Chao Sheng
    Fengju Song
    Ping Wang
    Yubei Huang
    BMC Cancer, 20